Filing Details

Accession Number:
0001127602-23-008584
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-03 11:22:03
Reporting Period:
2023-03-01
Accepted Time:
2023-03-03 11:22:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1110803 Illumina Inc. ILMN Laboratory Analytical Instruments (3826) 330804655
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727683 L Aimee Hoyt 5200 Illumina Way
San Diego CA 92122
Svp, Chief People Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-01 3,917 $199.06 2,881 No 4 S Direct
Common Stock Acquisiton 2023-03-01 6,926 $0.00 9,807 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Shares Acquisiton 2023-03-01 2,771 $0.00 2,771 $0.00
Common Stock Performance Shares Acquisiton 2023-03-01 4,156 $0.00 4,156 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,771 2024-12-29 No 4 A Direct
4,156 2025-12-28 No 4 A Direct
Footnotes
  1. The sale was made pursuant to a 10b5-1 plan.
  2. Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.
  3. Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.
  4. Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.